Last update :
17/04/2024
Antibiotic   Cefoxitin sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Altraxitina Portugal
Cefociclin Italy
Cefox Brazil
Cefoxit Brazil
Cefoxitin Australia, Austria, Canada, United States of America
Cefoxitina Argentina, Brazil, Colombia, Portugal, Spain
Cefton Brazil
Destrepen Greece
Foxitin Saudi Arabia, United Arab Emirates
Kefox Greece
Mefoxil Greece
Mefoxin Australia, Italy, Luxembourg, Netherlands, United States of America
Mefoxitin Austria, Germany, Switzerland, Venezuela
Metaptyl Sweden
Renoxitin Great Britain
Tifox Italy
Stability of mixtures   Injection   Stability of mixtures : Cefoxitin sodium     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 20 mg/ml
Injection   Cefoxitin sodium   
Injection   Clindamycin phosphate 9 mg/ml
25°C
48 Hour
Light 418
Level of evidence D
Glass Glucose 5% 5 mg/ml
Injection   Cefoxitin sodium   
Injection   Magnesium sulfate 10 & 20 mg/ml
25°C
20 Hour
Protect from light 630
Level of evidence D
Glass None 30 mg/ml
Injection   Cefoxitin sodium   
Injection   Metronidazole 5 mg/ml
25°C
2 Day
Protect from light 631
Level of evidence D
Glass None 30 mg/ml
Injection   Cefoxitin sodium   
Injection   Metronidazole 5 mg/ml
25°C
2 Day
Protect from light 631
Level of evidence D
Glass None 30 mg/ml
Injection   Cefoxitin sodium   
Injection   Metronidazole 5 mg/ml
5°C
12 Day
Protect from light 631
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Cefoxitin sodium   
Injection   Aztreonam 10 & 20 mg/ml
25°C
12 Hour
Not specified 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Cefoxitin sodium   
Injection   Aztreonam 10 & 20 mg/ml
4°C
7 Day
Protect from light 19
Level of evidence D

  Mentions Légales